Palvella Therapeutics (PVLA) Cash from Financing Activities (2013 - 2026)
Palvella Therapeutics (PVLA) recorded Cash from Financing Activities of $1.28 million in Q2 2026, up 266.8% from $349,000 a year earlier but down 99.4% from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Cash from Financing Activities (2013 - 2026) Analysis & Trends
On a TTM basis, Palvella Therapeutics' Cash from Financing Activities came in at $216.2 million as of Jun 30, 2026, up 183.2% year-over-year; for FY2025, it came in at -$660,000.
- Across earlier years, Cash from Financing Activities came in at $87.09 million in FY2024, $5 million in FY2023 (-30.7%), $7.21 million in FY2022 (-87.8%) and $59.13 million in FY2021 (+484.5%).
- Quarterly Cash from Financing Activities has ranged from -$14.78 million in Q4 2023 to $214.73 million in Q1 2026 over the past five years.
- Peak year-over-year performance for Cash from Financing Activities in the last five years was growth of 266.8% in Q2 2026, against a decline of 98.8% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $214.73 million (Q1 2026), -$49,000 (Q4 2025) and $242,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Palvella Therapeutics | 1.99 Bn | 1.73 Bn | - | 1.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.28 Mn |
| Mar 31, 2026 | 214.73 Mn |
| Dec 31, 2025 | -49,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Mar 31, 2025 | -1.20 Mn |
| Dec 31, 2024 | 74.79 Mn |
| Sep 30, 2024 | 2.41 Mn |
| Jun 30, 2024 | 9.89 Mn |
| Dec 31, 2023 | -14.78 Mn |
| Jun 30, 2023 | 19.78 Mn |
| Dec 31, 2022 | 93,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 281,000.00 |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 21.92 Mn |
| Jun 30, 2021 | 22.62 Mn |
| Mar 31, 2021 | 9.69 Mn |
| Dec 31, 2020 | 75,000.00 |
API Access
Palvella Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();